OCUL
Ocular Therapeutix, Inc.
NASDAQ · USHealthcareBiotechnology
$8.71-2.90%
Price as of Jul 20, 2026
OCUL valuation
Ocular Therapeutix, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.47x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.28x
- Price / sales
- 36.65x
- Price / cash flow
- -8.43x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 25.36x
- EV / EBITDA
- -4.81x
- EV / EBIT
- -4.41x
- Market cap
- $1.9B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.